GERICARE SENNA SYRUP- sennosides liquid 
ATLANTIC BIOLOGICALS CORP.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Per teaspoonful-5mL

Sennosides - 8.8 mg

Purpose

Laxative

Uses

Warnings

Do not use

Ask a doctor or pharmacis before use if you have

Stope use and ask a doctor if

you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.

If pregnant or breast-feeding ask a health professional before use

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center immediately

 Age Starting Dose Maximum dosage
 Adults and children 12 years and older 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor3 teaspoons in the morning and 3 teaspoons at bedtime
Under 12 years of age ask a doctor ask a doctor

Inactive ingredients artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, and sucrose.

Questions or comments? 1-800-540-3765

image 1

image 2

image 3

image 4

GERICARE SENNA SYRUP 
sennosides liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:17856-0462(NDC:57896-462)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.8 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:17856-0462-172 in 1 BOX, UNIT-DOSE01/18/2021
110 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
2NDC:17856-0462-372 in 1 BOX, UNIT-DOSE01/18/2021
25 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
3NDC:17856-0462-2120 in 1 BOX, UNIT-DOSE01/18/2021
32.5 mL in 1 SYRINGE; Type 0: Not a Combination Product
4NDC:17856-0462-448 in 1 BOX, UNIT-DOSE01/18/2021
45 mL in 1 SYRINGE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33405/01/2019
Labeler - ATLANTIC BIOLOGICALS CORP. (047437707)
Establishment
NameAddressID/FEIBusiness Operations
ATLANTIC BIOLOGICALS CORP.047437707relabel(17856-0462) , repack(17856-0462)

Revised: 1/2021
Document Id: 2aa4ea83-82cd-4d17-999a-58b275090ace
Set id: 8e1f2148-456a-4e53-801c-f72092d6268e
Version: 2
Effective Time: 20210118
 
ATLANTIC BIOLOGICALS CORP.